Guest guest Posted February 24, 2010 Report Share Posted February 24, 2010 Hi Alan Thank you for posting Dr, Meyers' response to your question about comencing ADT when surgery fails. I had a PSA of .689 5 weeks post surgery and .080 at 9 weeks I requested radiation therapy. Since this was not delayed long enough to determine a doubling time. However, the Radiation Oncologist I discussed my treatment with decided to radiate both my prostate and pelvic nodes. Even though my biopsy on the surgical specimen did not show node or seminal vessical involvement but did show capsular penetration and unclear margins, I felt this was a reasonable approach and agreed. My surgery was done on April 13, 2008 and I subsequently received 39 radiation treatments. My Gleason score was 9. And my oncologist also put me on Zolodex. I have received 3 of those shots and so far 2 PSA tests which were .007 and .01 respectively. My oncologist recommended that the ADT be continued for two years. Because of the side effects, I disagreed; and have opted for 1 year. I will receive the last shot in March. I feel that if I am followed carefully and if a recurrence happens I can always go back on the ADT. Dr. Meyers response to you makes me feel that I am on the right path. Thanks again for posting this. Harry Subject: When to start hormone therapy after a recurrenceTo: ProstateCancerSupport Date: Tuesday, February 23, 2010, 10:37 PM I asked Dr. "Snuffy" Myers, a well known medical oncologist specializing in prostate cancer, when was the right time to start hormone therapy after a recurrence. I thought his answer was very interesting My full question and his answer can be found at: http://prostatecanc eradvice. org/about/ myers/androgen- deprivation- therapy-after- surgery-or- radiation/ Alan Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.